Expression of soluble HLA-G in multiple myeloma patients and patients with renal failure

Leukemia Research

Volumn 36, Issue 7, 2012, Pages 881-883

  Wlasiuk, Paulina ^a   Stec, Anna ^a   Piechnik, Agnieszka ^a   Kaminska, Wioletta ^a   Dmoszynska, Anna ^a   Ksiazek, Andrzej ^a   Giannopoulos, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Multiple myeloma; Renal failure; SHLA G (soluble human lymphocyte antigen G); T regulatory cells (Treg)

Indexed keywords

CREATININE; HUMAN LYMPHOCYTE ANTIGEN G; LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; CREATININE; FEMALE; HLA-G ANTIGENS; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; OSMOLAR CONCENTRATION; RENAL INSUFFICIENCY; SOLUBILITY; YOUNG ADULT;

EID: 84862339359     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2012.02.015     Document Type: Article

References (18)

1. Mahindra A., Hideshima T., Anderson K.C. Multiple myeloma: biology of the disease. Blood Rev 2010, 24(Suppl. 1):5-11.
2. Becker N. Epidemiology of multiple myeloma. Recent Results Cancer Res 2011, 183:25-35.
3. Kovats S., Main E.K., Librach C., Stubblebine M., Fisher S.J., DeMars R. A class I antigen. HLA-G, expressed in human trophoblasts. Science 1990, 248:220-223.
4. Rebmann V., Regel J., Stolke D., Grosse- ilde H. Secretion of sHLA-G molecules in malignancies. Semin Cell Biol 2003, 13(5):371-377.
5. Campoli M., Ferrone S. Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands. Tissue Antigens 2008, 72(4):321-334.
6. Amiot L., Le Friec G., Sebti Y., Drénou B., Pangault C., Guilloux V., et al. HLA-G and lymphoproliferative disorders. Semin Cell Biol 2003, 13(5):379-385.
7. Rebmann V., Nückel H., Dührsen U., Grosse-Wilde H. HLA-G in B-chronic lymphocytic leukaemia: clinical relevance and functional implications. Semin Cell Biol 2007, 17(6):430-435.
8. Elliott R.L., Jiang X.P., Phillips J.T., Barnett B.G., Head J.F. Human leukocyte antigen G expression in breast cancer: role in immunosuppression. Cancer Biother Radiopharm 2011, 26(2):153-157.
9. Beyer M., Kochanek M., Giese T., Endl E., Weihrauch M.R., Knolle P.A., et al. In vivo peripheral expansion of naive CD4+ CD25high FoxP3+ regulatory T cells in patients with multiple myeloma. Blood 2006, 107(10):3940-3949.
10. Giannopoulos K., Schmitt M., Kowal M., Wlasiuk P., Bojarska-Junak A., Chen J., et al. Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia. Oncol Rep 2008, 20(3):677-682.
11. Le Maux A., Noël G., Birebent B., Grosset J.M., Vu N., De Guibert S., et al. Soluble human leucocyte antigen-G molecules in peripheral blood haematopoietic stem cell transplantation: a specific role to prevent acute graft-versus-host disease and a link with regulatory T cells. Clin Exp Immunol 2008, 152(1):50-56.
12. Carosella E.D., HoWangYin K.Y., Favier B., LeMaoult J. HLA-G- dependent suppressor cells: diverse by mature, function, and significance. Hum Immunol 2008, 69(11):700-707.
13. Wang Y., Ye Z., Meng X.Q., Zheng S.S. Expression of HLA-G in patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2011, 10(2):158-163.
14. Cao M., Yie S.M., Liu J., Ye S.R., Xia D., Gao E. Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer. Tissue Antigens 2011, 78(2):120-128.
15. Sebti Y., Le Maux A., Gros F., De Guibert S., Pangault C., Rouas-Freiss N., et al. Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders. Br J Haematol 2007, 138(2):202-212.
16. Giannopoulos K., Schmitt M., Kowal M., Własiuk P., Bojarska-Junak A., Roliński J., et al. The significance of soluble HLA-G plasma levels as well as messenger HLA-G for B-cell chronic lymphocytic leukemia (B-CLL). Leuk Res 2008, 32(12):1815-1819.
17. Carosella E.D., Gregori S., Rouas-Freiss N., LeMaoult J., Menier C., Favier B. The role of HLA-G in immunity and hematopoiesis. Cell Mol Life Sci 2011, 68(3):353-368.
18. Amiot L., Ferrone S., Grosse-Wilde H., Seliger B. Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?. Cell Mol Life Sci 2011, 68(3):417-431.